Pursuing personalized medicine for depression by targeting the lateral or medial prefrontal cortex with Deep TMS

BACKGROUND Major depressive disorder (MDD) can benefit from novel interventions and personalization. Deep transcranial magnetic stimulation (Deep TMS) targeting the lateral prefrontal cortex (LPFC) using the H1 coil was FDA cleared for treatment of MDD. However, recent preliminary data indicate that...

Full description

Bibliographic Details

Published in:	JCI Insight
Main Authors:	Abraham Zangen, Samuel Zibman, Aron Tendler, Noam Barnea-Ygael, Uri Alyagon, Daniel M. Blumberger, Geoffrey Grammer, Hadar Shalev, Tatiana Gulevski, Tanya Vapnik, Alexander Bystritsky, Igor Filipčić, David Feifel, Ahava Stein, Frederic Deutsch, Yiftach Roth, Mark S. George
Format:	Article
Language:	English
Published:	American Society for Clinical investigation 2023-02-01
Subjects:	Clinical trials Neuroscience
Online Access:	https://doi.org/10.1172/jci.insight.165271